These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6101155)

  • 1. Nitroglycerin pharmacokinetics after intravenous infusion in normal subjects.
    McNiff EF; Yacobi A; Young-Chang FM; Golden LH; Goldfarb A; Fung HL
    J Pharm Sci; 1981 Sep; 70(9):1054-8. PubMed ID: 6101155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose dependent pharmacokinetics of nitroglycerin after multiple intravenous infusions in healthy volunteers.
    Noonan PK; Williams RL; Benet LZ
    J Pharmacokinet Biopharm; 1985 Apr; 13(2):143-57. PubMed ID: 3932639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interpretation of nitrate plasma concentrations. Effect of cardiac output on nitroglycerin pharmacokinetics in experimental animals.
    Fung HL; Blei A; Chong S
    Eur Heart J; 1988 Jan; 9 Suppl A():39-43. PubMed ID: 3137071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics of glycerin trinitrate (nitroglycerin) after sublingual administration in patients with chronic ischemic heart disease].
    Blagodatskikh SV; Piotrovskiĭ VK; Metelits VI; Riabokon' OS; Martsevich SIu
    Farmakol Toksikol; 1987; 50(6):59-63. PubMed ID: 3125063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma concentrations and hemodynamic effects of intravenous, sublingual, and aerosolized nitroglycerin in patients undergoing cardiac catheterization.
    Curry SH; Lopez LM; Lambert CR; Kwon HR; Stack RK
    Biopharm Drug Dispos; 1993 Mar; 14(2):107-18. PubMed ID: 8453021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clevidipine: a review of its use in the management of acute hypertension.
    Deeks ED; Keating GM; Keam SJ
    Am J Cardiovasc Drugs; 2009; 9(2):117-34. PubMed ID: 19331440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antianginal effects of intravenous nitroglycerin over 24 hours.
    Zimrin D; Reichek N; Bogin KT; Aurigemma G; Douglas P; Berko B; Fung HL
    Circulation; 1988 Jun; 77(6):1376-84. PubMed ID: 3131041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of nitroglycerin after parenteral and oral dosing in the rat.
    Fung HL; Ogata H; Kamiya A; Maier GA
    J Pharm Sci; 1984 Jul; 73(7):873-9. PubMed ID: 6432996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of organic nitrates.
    Fung HL
    Am J Cardiol; 1987 Nov; 60(15):4H-9H. PubMed ID: 3120565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma concentrations and haemodynamic effects of nitroglycerin during and after intravenous infusion in healthy volunteers.
    Imhof PR; Sieber A; Hodler J; Müller P; Ott B; Fankhauser P; Chu LC; Gérardin A
    Eur J Clin Pharmacol; 1982; 23(2):99-106. PubMed ID: 6814928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable glyceryl dinitrate formation as a function of route of nitroglycerin administration.
    Noonan PK; Benet LZ
    Clin Pharmacol Ther; 1987 Sep; 42(3):273-7. PubMed ID: 3113806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glyceryl-1-nitrate pharmacokinetics in healthy volunteers.
    Laufen H; Leitold M
    Br J Clin Pharmacol; 1987 Mar; 23(3):287-93. PubMed ID: 3105569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of ritodrine administered intravenously: recommendations for changes in the current regimen.
    Caritis SN; Venkataramanan R; Darby MJ; Chiao JP; Krew M
    Am J Obstet Gynecol; 1990 Feb; 162(2):429-37. PubMed ID: 2309826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics of organic nitrates.
    Bogaert MG
    Clin Pharmacokinet; 1983; 8(5):410-21. PubMed ID: 6414751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steady state pharmacokinetic haemodynamic studies of intravenous nitroglycerin in congestive cardiac failure.
    Armstrong PW; Watts DG; Moffat JA
    Br J Clin Pharmacol; 1983 Oct; 16(4):385-90. PubMed ID: 6414501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incomplete and delayed bioavailability of sublingual nitroglycerin.
    Noonan PK; Benet LZ
    Am J Cardiol; 1985 Jan; 55(1):184-7. PubMed ID: 3917598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of ofloxacin after single and multiple intravenous infusions in healthy subjects.
    Farinotti R; Trouvin JH; Bocquet V; Vermerie N; Carbon C
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1590-2. PubMed ID: 3190187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemodynamic responses to glyceryl trinitrate: influence of rate and duration of delivery.
    Hargreaves AD; Muir AL
    Eur Heart J; 1992 Jul; 13(7):960-5. PubMed ID: 1644088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of cefepime in subjects with renal insufficiency.
    Barbhaiya RH; Knupp CA; Forgue ST; Matzke GR; Guay DR; Pittman KA
    Clin Pharmacol Ther; 1990 Sep; 48(3):268-76. PubMed ID: 2401125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma concentrations of glyceryl trinitrate and its dinitrate metabolites after sublingual administration to volunteers. Simultaneous determination of glyceryl trinitrate and its dinitrate metabolites.
    Jensen KM; Dahl JB
    Arzneimittelforschung; 1994 Aug; 44(8):951-3. PubMed ID: 7945539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.